Tag: anticoagulation
CX 2026: Venous and lymphatic session highlights continued innovation following recent PE trials
“Are we at the end of the road with this technology?” asked attendees of yesterday’s opening venous and lymphatic session at the 2026 Charing...
New STORM-PE data show improved functional outcomes with CAVT plus anticoagulation
The 90-day results of the STORM-PE randomised controlled trial (RCT) have demonstrated that patients with acute intermediate-high risk pulmonary embolism (PE) who were treated...
